UNIVERSITY OF SOUTHERN CALIFORNIA
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1880-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://startusc.com
Doxycycline Effects on Inflammation in Cystic Fibrosis
- First Posted Date
- 2011-03-25
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 21
- Registration Number
- NCT01323101
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation
- Conditions
- First Posted Date
- 2011-03-18
- Last Posted Date
- 2014-09-10
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 85
- Registration Number
- NCT01318005
- Locations
- 🇺🇸
USC University Hospital, Los Angeles, California, United States
Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery
- Conditions
- Interventions
- First Posted Date
- 2011-02-09
- Last Posted Date
- 2014-02-06
- Lead Sponsor
- University of Southern California
- Registration Number
- NCT01292083
Time Interval for Endoscopic Variceal Ligation
- First Posted Date
- 2011-02-08
- Last Posted Date
- 2017-02-13
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 90
- Registration Number
- NCT01291277
- Locations
- 🇺🇸
L.A. County + U.S.C. Medical Center, Los Angeles, California, United States
Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.
- Conditions
- Interventions
- First Posted Date
- 2011-01-13
- Last Posted Date
- 2014-08-01
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 4
- Registration Number
- NCT01276054
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
Avastin for PDR (Proliferative Diabetic Retinopathy)
- Conditions
- Interventions
- First Posted Date
- 2011-01-05
- Last Posted Date
- 2017-08-17
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 20
- Registration Number
- NCT01270542
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
- First Posted Date
- 2010-11-15
- Last Posted Date
- 2017-07-11
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 43
- Registration Number
- NCT01240629
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy
- Conditions
- Interventions
- First Posted Date
- 2010-11-11
- Last Posted Date
- 2015-05-27
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 7
- Registration Number
- NCT01238965
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
Alzheimer's Disease Neuroimaging Initiative 2
- First Posted Date
- 2010-11-01
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 1182
- Registration Number
- NCT01231971
- Locations
- 🇺🇸
University of Alabama, Birmingham, Birmingham, Alabama, United States
🇺🇸Banner Alzheimer's Institute, Phoenix, Arizona, United States
🇺🇸Banner Sun Health Research Institute, Sun City, Arizona, United States
Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2010-10-25
- Last Posted Date
- 2017-05-02
- Lead Sponsor
- University of Southern California
- Registration Number
- NCT01227408
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States